World's Best Scientists 2026 revealed!
Award Badge
Microbiology
Korea
2026

D-Index & Metrics

Microbiology

D-Index
73
Citations
32381
World Ranking
1616
National Ranking
5

Myoung-don Oh publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Myoung-don Oh sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 417 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Myoung-don Oh D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Myoung-don Oh sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 73 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Microbiology in Korea Leader Award
  • 2025 - Research.com Microbiology in Korea Leader Award

Overview

Myoung-don Oh is affiliated with Seoul National University in South Korea. Their research primarily focuses on medicine, with an emphasis on infectious diseases, epidemiology, oncology, neurology, and molecular medicine.

The scientist's notable recent publications include:

  • "Remdesivir for the Treatment of Covid-19 - Final Report" (2020), published in the New England Journal of Medicine
  • "Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19" (2020), published in the New England Journal of Medicine
  • "A minimal common outcome measure set for COVID-19 clinical research" (2020), published in The Lancet Infectious Diseases
  • "COVID-19: towards controlling of a pandemic" (2020), published in The Lancet
  • "The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures" (2020), published in the Journal of Korean Medical Science

The main topics covered in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing
  • COVID-19 and healthcare impacts
  • Neutropenia and Cancer Infections

Frequent co-authors collaborating with Myoung-don Oh are:

  • Nam Joong Kim
  • Chang Kyung Kang
  • Wan Beom Park
  • Pyoeng Gyun Choe
  • Eu Suk Kim

The scientist has published extensively in several journals, including:

  • Journal of Korean Medical Science
  • Open Forum Infectious Diseases
  • Emerging Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Korean Journal of Internal Medicine

The scope of Myoung-don Oh's work is marked by a strong focus on infectious diseases, particularly relating to the COVID-19 pandemic, as well as broader topics in epidemiology and bacterial resistance. Their publication record demonstrates active engagement in both clinical and molecular research domains.

Best Publications

  • Remdesivir for the Treatment of Covid-19 - Final Report.

    John H. Beigel;Kay M. Tomashek;Lori E. Dodd;Aneesh K. Mehta

  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

    Andre C Kalil;Thomas F Patterson;Aneesh K Mehta;Kay M Tomashek

  • A minimal common outcome measure set for COVID-19 clinical research

    John C. Marshall;Srinivas Murthy;Janet Diaz;Neil Adhikari

  • COVID-19: towards controlling of a pandemic.

    Juliet Bedford;Delia Enria;Johan Giesecke;David L Heymann

  • Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome

    Cheol-In Kang;Sung-Han Kim;Wan Beom Park;Ki-Deok Lee

  • Severe fever with thrombocytopenia syndrome, South Korea, 2012.

    Kye-Hyung Kim;Jongyoun Yi;Gayeon Kim;Su Jin Choi

  • Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical Outcome

    Cheol-In Kang;Sung-Han Kim;Hong-Bin Kim;Sang-Won Park

  • Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

    David S. Hui;Esam I. Azhar;Yae Jean Kim;Ziad A. Memish;Ziad A. Memish

  • The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial

    Wan Beom Park;Nak Hyun Kim;Kye Hyung Kim;Seung Hwan Lee

  • The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures.

    Jin Yong Kim;Pyoeng Gyun Choe;Yoonju Oh;Kyung Joong Oh

  • Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy

    Cheol-In Kang;Sung-Han Kim;Wan Beom Park;Ki-Deok Lee

  • Outcome of Vancomycin Treatment in Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia

    Sung Han Kim;Kye Hyung Kim;Hong Bin Kim;Nam Joong Kim

  • Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19

    Eu Suk Kim;Bum Sik Chin;Chang Kyung Kang;Nam Joong Kim

  • Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.

    Kayvon Modjarrad;Christine C. Roberts;Kristin T. Mills;Amy R. Castellano

  • Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-β-Lactamase-Producing Klebsiella pneumoniae

    Hyunjoo Pai;Cheol In Kang;Jeong Hum Byeon;Ki Deok Lee

  • Virus Isolation from the First Patient with SARS-CoV-2 in Korea.

    Wan Beom Park;Wan Beom Park;Nak Jung Kwon;Su Jin Choi;Chang Kyung Kang

  • A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.

    Cheolmin Kim;Dong Kyun Ryu;Jihun Lee;Young Il Kim

  • MERS-CoV Antibody Responses 1 Year After Symptom Onset, South Korea, 2015

    Pyoeng Gyun Choe;R. A.P.M. Perera;Wan Beom Park;Kyoung Ho Song

  • Viral Load Kinetics of MERS Coronavirus Infection.

    Myoung Don Oh;Wan Beom Park;Pyoeng Gyun Choe;Su Jin Choi

  • Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea.

    Myoung Don Oh;Wan Beom Park;Sang Won Park;Pyoeng Gyun Choe

  • Diagnostic Usefulness of a T-cell–Based Assay for Extrapulmonary Tuberculosis

    Sung-Han Kim;Su-Jin Choi;Hong-Bin Kim;Nam-Joong Kim

  • Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection.

    Eu Suk Kim;Pyoeng Gyun Choe;Wan Beom Park;Hong Sang Oh

Frequent Co-Authors

Eui Chong Kim
Eui Chong Kim Seoul National University
Cheol-In Kang
Cheol-In Kang Sungkyunkwan University
Ki-Hyun Kim
Ki-Hyun Kim Hanyang University
Ziad A. Memish
Ziad A. Memish Emory University
Seock-Ah Im
Seock-Ah Im Seoul National University Hospital
Dong-Wan Kim
Dong-Wan Kim Seoul National University Hospital
Ranawaka A.P.M. Perera
Ranawaka A.P.M. Perera University of Hong Kong
Malik Peiris
Malik Peiris University of Hong Kong
Leo L. M. Poon
Leo L. M. Poon University of Hong Kong
Young Ki Choi
Young Ki Choi Institute for Basic Science

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, exploring related online degrees can open diverse career opportunities beyond traditional laboratory roles. Fields like healthcare and information management increasingly require specialized skills that complement microbiology knowledge.

One important consideration is accessibility—many are curious about the best degree for felons, highlighting programs that offer second chances and flexible pathways for those with past convictions. Microbiology-related fields can align well with such accessible degree options, especially in allied health or administrative roles.

Another growing area is in integrative health, such as becoming a functional medicine NP. This role combines clinical expertise with a holistic approach, which pairs well with microbiological insights into infection and immune system functions.

For those interested in healthcare data, earning a professional coder certification or pursuing a bachelor of science in health information management salary-oriented degree can expand career prospects in health information systems, medical billing, and coding. These fields rely on precise microbial and clinical data knowledge, making them ideal complementary pathways for microbiology graduates.

Best Scientists Citing Myoung-don Oh

Trending Scientists